New Jersey, USA-based cancer giant Merck & Co (NYSE: MRK) has announced it will unveil a comprehensive slate of new research ...

Swiss pharma giant Novartis will spotlight key data across its oncology portfolio, including Kisqali (ribociclib), Scemblix ...

USA-based Inozyme Pharma, a biopharma developing innovative therapeutics for rare diseases that affect bone health and blood ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the Phase III KEYNOTE-B96 trial, also known as ENGOT-ov65, met ...

In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration (FDA), said ...

US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...

Swedish biotech firm PeptiSystems has joined forces with Asahi Kasei Bioprocess America in a global partnership set to ...